)
Visual
test
Tenon Medical
Tenon Medical (TNON) investor relations material
Tenon Medical Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration Filing summary10 Dec, 2025
Company overview and business model
Medical device company focused on minimally invasive sacroiliac (SI) joint fusion solutions for lower back pain, with FDA-cleared Catamaran SI Joint Fusion System and recent acquisition of SImmetry SI Joint Fusion System assets.
Targets three commercial opportunities: primary SI joint procedures, revision of failed implants, and SI joint fusion adjunct to spine fusion.
National commercial launch of Catamaran System began in October 2022, emphasizing a single-implant, less invasive approach with proprietary features.
Acquired assets from SiVantage, Inc. and SIMPL Medical, LLC in August 2025 to expand product offerings and market reach.
Market opportunity and competitive landscape
Over 30 million American adults suffer from chronic lower back pain; 15–30% is associated with the SI joint.
Surgical penetration for SI joint pain remains low (5–7%) due to complexity and suboptimal existing solutions, presenting significant growth potential.
Catamaran System aims to address limitations of current treatments with a direct, visualized, single-implant approach and radiographic confirmation of fusion.
Financial performance and metrics
Raised approximately $2.85 million in gross proceeds from a private placement in November 2025.
Common stock listed on Nasdaq Capital Market under symbol "TNON"; closing price was $1.11 per share on December 8, 2025.
SI-Joint surgical market penetration strategy
Cumulative dilution from all outstanding securities?
Catamaran study completion impact on adoption?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebJ
Strong growth, digital innovation, and margin expansion drive robust multi-year financial outlook. - 6 Feb004020
Operating profit rose on cost savings and high-value sales, with major US expansion underway. - 6 FebJOUT
Net sales up 31%, gross margin at 36.6%, and net loss narrowed to $3.3 million. - 6 FebPECO
Record 2025 occupancy and 7% Core FFO growth; 2026 targets 5.5% FFO growth and strong acquisitions. - 6 FebPROV
Q2 FY2026 net income rose 65% year-over-year, with higher margins and strong credit quality. - 6 FebNVDA
AI-driven digital twins and accelerated computing are set to revolutionize industrial design and manufacturing. - 6 FebCDP
2025 FFO/share rose 5.8% to $2.72, with strong leasing and investment; 2026 guidance signals more growth. - 6 FebCRI
Q1 2025 saw record revenue, a return to profit, and major new contracts in space technology. - 6 FebCRINet loss widened to 7.5m PLN in H1 2024 as revenue fell and R&D costs remained high.
- 6 FebCRINet loss deepened on lower sales and higher costs, but major new contracts and restructuring are underway.
Next Tenon Medical earnings date
Q4 202519 Mar, 2026
Tenon Medical
Next Tenon Medical earnings date
Q4 202519 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Tenon Medical Inc. is a medical device company focused on the development and provision of surgical implant systems designed to treat severe lower back pain in the United States and Puerto Rico. The company's flagship product, the CATAMARAN SI-Joint Fusion System, is engineered to fuse sacroiliac joints (SI-Joints) to address SI-Joint dysfunction, a common cause of severe lower back pain. This system features a fixation device that traverses the axial and sagittal planes of the ilium and sacrum, thereby stabilizing and transfixing the SI joints for improved patient outcomes. Founded in 2012, Tenon Medical has established itself in the healthcare sector, specifically within the medical devices industry, by innovating solutions aimed at improving the quality of life for patients suffering from back pain due to SI-Joint dysfunction. The company is headquartered in Los Gatos, California, and its shares are listed on the Nasdaq.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage